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Abstract: 
The expansion of trinucleotide repeats in human genomic DNA manifests into multiple 
neurodegenerative diseases (Amrane et al., 2005). At least nine human diseases stem from the 
expression of expanded trinucleotide repeats (Box, 2007). Simple sequences such as, 
5’CAG/CTG’3 repeats, contain a potential pathogenicity once expanded past their original 
lengths; which is exemplified in Huntington’s Diseases and Myotonic Dystrophy. Once 
expanded CAG repeats are transcribed into RNA, these transcripts are translated, and the mal 
functioning proteins can lead to severe cell damage. Furthermore, the repeats can be passed 
down through generations, and in each germline, continuously expanding, gaining more 
repeated units (Orr & Zoghbi, 2007)-(Hartenstine, Goodman, & Petruska, 2000). Moreover, 
an increasing length of CAG repeats is directly correlated with an increase in the severity of 
the aforementioned diseases (Orr & Zoghbi, 2007)-(Hartenstine et al., 2000). In addition, the 
mechanisms by which elongated CAG repeats operate in vivo remains unknown; however, 
past literature denotes structural and functional aspects of CAG tracts (Zhang, Huang, Gu, & 
Li, 2012)-(Broda, Kierzek, Gdaniec, Kulinski, & Kierzek, 2005). These past studies were 
performed on shorter repeat lengths of 10-80, while in vivo, CAG sequences  reach over 100 
repeats in length (Petruska, Arnheim, & Goodman, 1996)-(Hartenstine, Goodman, & 
Petruska, 2002). The heterogeneity of these repeats reflect the innate replication difficulties 
present in in vitro studies and physiological conditions in Huntingtins and Myotonic 
Dystrophy (Lin & Wilson, 2011)- (Cooper, 2009). Petruska hypothesizes that when CAG 
repeats are being replicated, the strand forms structures that facilitated Taq’s ability to jump 
over sequences and leave shortened replicons (Petruska et al., 1996). Furthermore, we aim to 
detect the heterogeneity of (CAG)n products after PCR amplification. By initially amplifying 
repeats 10-150 with long primers, we are able to verify the change in CAG sequence length 
after cutting the primers off with an enzymatic double digestion. In addition, (CAG)10-150 
were amplified once more with smaller series of primers: this enabled us to view how 
increasing CAG length induces a more heterogeneous product after PCR.CAG 10 through 60 
show strong bands on agarose gels; however, the bands become less intense, and eventually 
degrade into complete smears with increasing length. This is seen in repeats 100, to 120, and 
then 150. The small primers allow us to view this degradation. The smear of (CAG)150 
displays a variety of repeats at different lengths; and a way to detect this variety is through a 
binding assay. SYBR Green is a chemical agent that fluoresces once bound to double 
stranded DNA. Doxorubicin- also called Daunomycinone- a well-known anticancer drug, 
naturally fluoresces. Once bound to double stranded DNA, Doxorubicin’s fluoresces is 
quenched (Das & Kumar, 2013). Utilizing these two fluorophores will allow us to detect 
heterogeneity after PCR amplifications (Ning et al., 2015)-(Chan et al., 2012). By titrating in 
select CAG repeats after PCR we can record changes in fluorescence spectra and determine 
whether the amplicons are the correct length (Ning et al., 2015)-(Gatchel & Zoghbi, 2005). 
the Fluromax-3 Fluorimeter, we can record the fluorescence quenching of Doxorubicin by 
titrating in select CAG sequences (Ning et al., 2015)-(Gatchel & Zoghbi, 2005). 
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Introduction: 
Trinucleotide repeats are a common feature of genomes across multiple organisms (Li & 
Bonini, 2010)-(Usdin, 2008). These repeats often display instability or inconsistency in DNA 
structural integrity (Li & Bonini, 2010)-(Usdin, 2008). The expansion of trinucleotide repeats 
in human genomic DNA manifests into multiple neurodegenerative diseases (Li & Bonini, 
2010)-(Mirkin, 2007). At least nine human diseases stem from the expression of expanded 
non-coding trinucleotide repeats (Mirkin, 2007)-(Usdin, 2008). Simple sequences such as, 
5’CAG/CTG’3  repeats, contain a potential pathogenicity once expanded past their original 
lengths, which is exemplified in Huntington’s Diseases and Myotonic Dystrophy (Mirkin, 
2007)-(Usdin, 2008). The variability in repeat size governs the wide range of phenotypes 
associated in these diseases (Mitas, 1997). When expanded CAG repeats are transcribed into 
RNA, these transcripts are translated, and these mal functioning proteins can lead to severe 
cell damage (Li & Bonini, 2010)-(Usdin, 2008). Furthermore, while in the genome, the 
repeats can be passed down through generations in the germline, continuously expanding, and 
gaining more repeated units (Orr & Zoghbi, 2007)-(Hartenstine et al., 2000). This germline 
instability can cause an earlier onset age of the disease, and a more rapid progression (Mirkin, 
2007)-(Mitas, 1997)-(Sobczak & Krzyzosiak, 2005).    Moreover, an increasing length of 
CAG repeats is directly correlated with an increase in the severity of the aforementioned 
diseases (Orr & Zoghbi, 2007)-(Hartenstine et al., 2000). In addition, the mechanisms by 
which elongated CAG repeats operate in vivo remains unknown; however, past literature 
denotes structural and functional aspects of CAG tracts (Zhang et al., 2012)-(Broda et al., 
2005). These past studies were performed on shorter repeat lengths of 10-80, while in vivo, 
CAG sequences  reach over 100 repeats in length (Petruska et al., 1996)-(Hartenstine et al., 
2002). Normal individuals have only 11 to 34 copies of 5’CAG/CTG’3 repeats; whereas 
those afflicted with Huntington’s have upwards of 37 to 86 copies (Mariappan et al., 1998). 
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Studies have tried elucidated the expansion of CAG repeats in certain model organisms 
(Callahan, Andrews, Zakian, & Freudenreich, 2003), but  the dynamic structure of these 
repeats is exemplified in Certain difficulties arise when studying such long CAG sequences 
in vitro as well (Sobczak et al., 2010)-(Sobczak & Krzyzosiak, 2005). The amplification of 
long repeats via Polymerase Chain Reaction (PCR) often leads to an unwanted stochastic 
shortening of DNA product- which is seen in CAG150 (Hartenstine et al., 2000)-(Stephenson, 
Keller, Tenenbaum, Zuker, & Li, 2014) . Petruska hypothesizes that when CAG repeats are 
being replicated, the strand forms structures that facilitated Taq’s ability to jump over 
sequences and leave shortened replicons (Petruska et al., 1996). The PCR product of 
(CAG)150 also appears as a smear after being ran on an agarose gel; this smear represents a 
population of CAG repeats at different lengths. (CAG)150 presents with an inherent 
heterogeneity after amplification. This heterogeneity is also seen in lengthier repeats like 100 
and 120, and these lanes also present with shortened products of after PCR, which laid above 
weak bands of correct CAG length. We aim to further study the heterogeneity of CAG repeats 
by displaying how the trinucleotide repeats sequence lengthens, and detecting these different 
lengths after PCR amplification. Initially a store of amplicons will be made with long 
oligonucleotide primers. Then using restriction enzymes, we will cut off the primers and 
visualize the change in (CAG)n sequences on an agarose gel. Afterwards, we will amplify 
repeats 10 through 150 with shorter primers. This will enable us to view the eventual shift of 
strong bands from shorter CAG lengths, to complete smears with longer repeats. This 
degradation is displayed with the amplicons of CAG 100, 120 and 150.  Furthermore, with 
this varied store of CAG repeats, we can perform experiments that quantify the DNA product 
through utilization of fluorescence assays. Through fluorescence, we can quantify the CAG 
product and detect changes in length after PCR. An established anticancer drug, Doxorubicin- 
also known as Dyanomicin- will be used to detect the biding of CAG repeats through 
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fluorescence quenching (Karukstis, Thompson, Whiles, & Rosenfeld, 1998). Doxorubicin is a 
drug often prescribed after a diagnosis of malignant tumours (Das, Bhadra, Achari, 
Chakraborty, & Kumar, 2011). Doxorubicin binds to double stranded DNA of tumour cells 
and disrupts essential cellular functions (Das et al., 2011). Doxorubicin continuously 
fluoresces; however, once bound to 5’-GC-3’ or 5’-GC-3’ sequences of CAG tracts, a sharp 
decrease in fluoresces intensity is recorded (Ning et al., 2015)-(Hovorka et al., 2010). (CAG)n 
repeats that are rich in guanine (G) and cytosine (C). These repeats are susceptible to forming 
stable intramolecular structures (Ning et al., 2015). The chemical structure of Doxorubicin 
contains aromatic rings that are able to intercalate into the double strands of CAG repeats, 
and successfully bind to Watson-Crick base pairs (Box, 2007)-(Tran et al., 2014). Through 
spectroscopy techniques, we plan on titrating in varying concentrations of CAG repeats- and 
different lengths- into solution of Doxorubicin and associated buffer (Ning et al., 2015)-
(Hovorka et al., 2010). This will allow us to observe how well Doxorubicin binds to longer 
repeats like CAG150, and test how its natural heterogeneity after amplification affects these 
interactions (Changenet-Barret, Gustavsson, Markovitsi, Manet, & Monti, 2013). Later on, 
we can also perform experiments on how well Doxorubicin binds to single stranded CAG 
repeats(Das & Kumar, 2013) 
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Goals: 
Our. We aim to investigate the heterogeneity of (CAG)n products after PCR amplification. 
The amplicons of CAG repeats are not all uniform in length: the CAG sequences varies in 
length after replication. We plan on developing techniques to detect changes in sequence 
length in order to better depict this inherent heterogeneity of CAG repeats. Initially, we plan 
on performing PCR experiments of (CAG)10-150 with long oligonucleotide primers. With this 
initial amplification, we will then perform a double digestion reaction with enzymes BamHI 
and SallHF. These enzymes will cut off the primers leaving only the CAG sequences intact. 
Running the cut sequences on an agarose gel will reveal whether the repeats changed in 
length after the PCR amplification. Afterwards, we will then amplify (CAG)10-150 with shorter 
primers. Utilizing shorter primers will allow us to monitor the effect of replication on each 
repeat length. Repeats of lengths 10 through 60 display solid, intense bands on an agarose 
gel; however, the bands begin to become fainter, and degrade into smears at lengths of 100 
through 150. Using shorter primers provides a more accurate representation of how the CAG 
sequences are altered after amplification. We aim to view the degradation of strong bands, 
into fainter bands, and then smears. This is exemplified in the transition of CAG 100, 120, 
and 150. The next step in detecting the heterogeneity in these repeats is to develop a binding 
assay. We plan on using fluorophores to bind to CAG products after PCR. Tracking the 
intensities of the fluorescence that each repeat length emits will allow us to detect changes in 
sequence length. Doxorubicin (Dox) is a fluorophore that emits light in solution, except once 
bound to double stranded DNA: this intercalation into double stranded CAG repeats causes 
fluorescence quenching. The decrease in fluorescence allows us to track which CAG length is 
binding to Dox. Also, doxorubicin binds specifically to 5’GC’3 and 5’CG’3base pairs. 
Therefore, utilizing Dox in a binding assay with (CAG)n amplicons will allow us to detect 
changes in the original length of after PCR.                 
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Method and Materials: 
 
PCR with 3.0kb Primers: 
We began with amplifying repeats of CAG10-100 
with long primers-as displayed in Figure 1- in PCR 
using Taq Polymerase (New England Bio Labs) to 
replicate the DNA, as seen in the PCR Protocols on 
Tables 1 and 2, and Thermal Cylcer Procedure on 
Table 3. We used Taq in order to display the 
heterogeneity in product after amplification. We 
used a 2720 Thermal Cycler from Bio Rad. A 
thermo buffer was used during these procedures 
from New England Bio Labs. In order to amplify 
CAG150 correctly, we used Q5 High Fidelity 
Polymerase (New England Bio Labs); and Q5 
Reaction Buffer was used for this reaction. We use 
Q5 Polymerase instead of Taq because of CAG150’s 
structural polymorphism; thusly, producing 
amplicons of the correct length. For both reactions, 
we used pUCTf –the forward primer- and pUCBr- 
the reverse primer. We then ran the PCR product 
on 0.8% agarose gels to correctly identify the size 
of the DNA amplified. Directly after PCR, 
purifying the product with a GeneJet Brand DNA 
Purification kit was the next step. With this pure 
Table 1: PCR at .5mL Protocol  
  uL 
cag repeats 10-100 
vector (10ng/uL) 10 
Primer 1 (100uM) 5 
Primer 2 (100uM) 5 
dNTPs (25mM) 4 
Buffer 50 
H2O 420 
Tap poly. 4 
  498 
 
Separate each 500uL into five 
100uL samples.  
Then perform PCR at p53 handle.  
 
  
 
 
 
Table 2: PCR at .5mL Protocol  
  uL 
cag repeats 150 
vector (10ng/uL) 10 
Primer 1 (100uM) 5 
Primer 2 (100uM) 5 
dNTPs (25mM) 4 
Q5 RXN Buffer 50 
H2O 420 
Q5 poly. 4 
  498 
  
 
Separate each 500uL into five 
100uL samples.  
Then perform PCR at p53 handle.  
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CAG DNA, we will then analyse it once more on a 0.8% agarose gel. This gel was made 
from 0.24g of agarose powder, along with 30mL of 10% Tris Buffer. The DNA on the gel 
was seen from a scanned 
image from a Typhoon Trio, 
on 526nm and 450700pmt 
emission settings for Figures 
3 through 8.  We also 
confirmed the correct 
replication of the PCR 
product by measuring their 
concentrations with a 
Nano Drop instrument - 
as seen on Table 5. The 
Nano Drop apparatus 
allows us to determine 
the concentrations of 
our amplified CAG 
repeats by only using 
1µL of solution, with 
ng/µL precision. These 
measurements were 
compared with Dr. Li’s 
Nano Drop 
concentrations, 
providing reassurance of the results. 
Table 3: Thermal Cylcer Procedure 
1. Choose p53 handle Procedure 
A: PCR Amplification Steps 
1. Heat to 95°C: Denaturation of Strands 
2. Cool to 55°C: Anealing of Primers to Target Sequence  
3. Heat to 75°C: Taq Begins Amplification  
4: Repeat Steps 1, 2, and 3 for 30 Cycles 
5. Cool to 4°C: Ensuring the Stop of Amplification and Mimic 
Refrigeration. 
 
 
Figure 1: The methods for purifying CAG/DNA samples- in either 
linear templates or circular plasmids- are depicted in the figure 
above. After amplifying the repeats, the handles used in PCR would 
be cut off by Restriction Enzymes. Then the size of the purified 
samples will be analyzed on an agarose gel. 
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PCR Conditions: 
The p53 handle program consisted of a series of –commonly 30- rounds of precise 
temperature changes termed cycles. Within each cycle, minute temperature fluctuations 
govern the replication of DNA. Initially, heating of the reaction vessel to 95 °C for 20 to 
thirty seconds is performed in order to denature the strands of template. The high 
temperatures elicit DNA melting through breaking of the hydrogen bonds between 
complementary bases, thereby producing two single stranded DNA.  Next, the reaction 
temperature is lowered to 55 °C for 20-40 seconds, admitting the primers to anneal onto the 
single stands of DNA. This annealing step has to be extremely precise because of the 
hybridization of the primers to the template. The temperature needs to remain low enough to 
permit hybridization, while maintaining a temperature high enough allowing for specificity of 
binding. This delicate balance is essential for the primers properly binding to the 
complimentary sequences on the template strand. An excessively high temperature will 
completely inhibit binding, and a temperature too low will induce incorrect binding. In 
addition, the annealing temperature is usually 3 to 5 °C below the melting temperature (Tm) 
of the primers used. Incorrect annealing temperature inevitably cause replication errors as the 
reaction progresses. The next step consist of synthesizing a new DNA strand: the elongation 
phase. The temperature at this step is dependent on the DNA polymerase in the reaction. Taq 
polymerase’s optimum activity is placed at 75 °C. The thermal cycler then heats up from 55 
°C to 75°C, which enables Taq to attach to the primer/template strand, and begin synthesizing 
a complimentary DNA sequence. Taq creates this new daughter strand by adding dNTP’s that 
are complementary to the template in a 5’ to 3’ direction. The time of this elongation phase is 
dictated by the enzymatic activity of the polymerase and the length of the desired DNA 
fragment amplified to be amplified. DNA polymerases at their respective optimized 
temperatures, are able to synthesize a thousand base pairs per minute. Therefore, during 
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optimal conditions, the only limiting aspect of the PCR is the amount of substrate. DNA 
polymerases are able to double the amount of targeted DNA each extension phase, thereby, 
causing an exponential increase of amplified DNA product. After elongation, the 
temperatures revert to the previous steps, and continues this process for 30 cycles. Once these 
cycles run to fruition, the final holding phase begins: the thermal cycler cools to 4°C, 
mimicking a temporary storage unit for the newly amplified product.  
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Enzymatic Double Digestion: 
Furthermore, restriction 
enzymes will then be 
used to cut the long 
primers from the CAG 
repeats, thereby, 
indicating –with more 
specificity– how PCR 
replication affects the repeat lengths. As seen in Figure 1, the pair of the restriction enzymes 
that will be used are BamHI and Sall. Bam HI is a restriction endonuclease that binds at 
the recognition sequence 5'-GGATCC-3', and cleaves these sequences just after the 5'-
guanine on each strand (New England Bio Labs). This cleavage results in sticky ends which 
are 4 base pairs long. Sal III is also a restriction endonuclease, however, it binds at the 
palindromic 5’-GTCGAC-‘3 and cleaves in between the first guanine and thymine form the 
5’ end (New England Bio Labs). Table 4 depicts the protocol of how we tested each enzymes 
ability. Sample A is the control with no restriction enzymes; B contains only BamHI; C 
contains only Sall HF; and D both. After verifying how effective both enzymes are with 
sample D, we then replicated the double digest reactions with repeats 10 through 150.  
 
 
 
 
 
Table 4: Double Enzymatic Digestion Protocol  
Vol (µL) A B C D 
DNA 3 3 3 3 
Buffer 2 1 1 1 1 
BSA 1 1 1 1 
BamHI - 1 - 1 
Sal HF - - 1 1 
H2O 4 3 3 2 
Total 
Volume 
10 10 10 10 
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PCR with 1kb & 40bp Primers: 
The short PCR 
experiments were 
performed in the same 
conditions as the long 
PCR’s, as depicted in 
Table 1. The first set of 
short primers we used 
were the G series primers 
(1kb). The second set 
utilized was the M series (40bp). The M series are much shorter than the G primers. In 
addition, Figure 2 displays process of how short PCR will be run. The fluorescence assay was 
conducted with the purified PCR product made with M series primers. In order to correctly 
identify the repeats that we will be working with, we replenished our stock of CAG repeats 
by creating PCR volumes of 0.5mL. Dealing with the short PCR, we then purify the PCR 
products made from both the G and M series primers with the same GeneJet Brand DNA 
Purification kit. We also recorded the concentrations of each purified product from both sets 
of primers, with the same conditions as the long PCR products as seen in Tables 6, and 7.  
 
 
 
 
 
 
Figure 2: Representing the methodical steps in our plan, (CAG)n 
repeats will be amplified via PCR with various small primers. The 
length of these Primer handles will be heterogeneous at different 
CAG repeat lengths. 
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Binding Assay Procedure:  
The fluorescence binding assay will consist of SYBR Green, Doxorubicin (dissolved in 
DMSO) and a 10mM Tris Buffer at a 7.4 pH. The Tris Buffer also contains 50mM NaCl. 
Utilizing fluorescence to tract the varying lengths of repeats in the heterogeneous population 
of the PCR product. Changes in fluorescence recordings will alert to alterations in (CAG)n 
length compared to the First we will excite a solution of SYBR Green and 10mM Tris Buffer 
under UV light. We will use a UV 1800 Shimadzu to emit UV light. This will ensure the 
emission spectra of SYBR Green. In addition, a solution of the buffer and the fluorescent 
chemical will have M-series (CAG)10-150 products titrated in, and change in intensity 
recorded. Furthermore, the Fluorescence Intensities will be recorded with Fluromax-3 
Fluorimeter. In order to test whether the fluorescent dye bound DNA to all of the binding 
sites we conducted experiments with multiple concentrations of CAG 60. We collected the 
fluoresce intensities with the Nano Drop Fluorimeter 3300.       
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Results: 
PCR with 3.0kb Primers: 
The difficulties of amplifying long CAG 
repeats are seen in our gel images. The 
PCR experiments for the repeats were all 
successfully produced, as seen in Figures 3 
and 4; with a DNA Ladder as a control, 
the amplification of the DNA is shown as 
consecutive clear bands at 3 kbp. On 
Figure 3, CAG10 did no amplify well. 
However, the difficulties of replicating 
CAG10 were quickly rectified by simply 
redoing the PCR once more. Error may 
have originated from pipetting error while 
assembling the PCR experiment. We also 
added an extra 100uL of amplified CAG10 
from previous test PCR’s, and pooled the total CAG10 together, then ran it on the gel in 
Figure 4. This pooled product displayed a strong dark band, and the fact that the extra DNA 
was added is shown in the high concentration of 407.9 ng/µL, as seen in Table 5. CAG 
sequences between 20 and 100 repeats have concentrations between 200 ng/µL and 300 
ng/µL. CAG150 also had a high concentration compared to the other repeats, at 394 ng/µL; 
however, this is expected due to its longer sequence. Furthermore, the way the CAG bands 
rise in accordance to increase repeat length verifies that the DNA product was correctly 
amplified, and purified- as seen in Figures 3 and 4. Moreover, the band of CAG150 being 
lower than 100 or 60, only exemplifies the intricate and complexity of CAG150 structure.  
 
Figure 3: This gel image displays the 
amplification of (CAG)10-150. Bands of each 
repeat are clearly shown expect for CAG10. The 
reagents for CAG10 must not have properly 
reacted. However, for all the other the repeats, 
an increase in length, is verified with an 
increase in size, as seen in the rising bands in 
each lane. (CAG)150 depicts a lower weight than 
100 or 60 despite its shorter length; thus, 
signifying its natural unstable and complex 
nature.  
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Figure 4: This gel image clearly displays 
(CAG)10-150 repeats after PCR amplification, and 
purification. CAG10 was re-amplified, and purified 
once more.  As the repeats increase in length, an 
increase in size is also shown for (CAG)10-100. 
(CAG)150 depicts a lower weight than 100 or 60 
despite their shorter length.  
Table 5: (CAG)10-150 3.0kb Primer     
Concentrations   
(CAG)n (ng/µL) A260nm  
10 407.9 8.159 
20 248 4.96 
30 227.1 4.541 
40 272.1 5.442 
60 227.1 4.541 
100 196.3 3.926 
150 394 7.879 
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Enzymatic Double Digestion: 
The double digestion of the long PCR 
products highlights the heterogeneity 
that manifest in CAG repeats. Faint 
bands are present in the 25bp to 50bp 
for CAG's 10-30, as seen on Figure 5. 
Faint bands are also present on 
the 100bp range for CAG 40. CAG 60 
shows a band in the 100-150bp region; 
and CAG 150 contains a smear at that 
weight. Ideally the image should 
present the CAG lengths at their 
correct sizes; however, during 
amplification the lengths of the repeats 
are altered. This gel displays the innate 
heterogeneity of CAG sequences after 
amplification. In the case of CAG 150, 
lengths of differing sizes are created. 
When these multiple lengths are ran on 
a gel, they produce a smear. Furthermore, Figure 5 displays the correlation between increased 
length, and heterogeneity manifestation. From 10 to 150, the bands become less and less 
defined, and eventually become a smear.  
 
 
 
Figure 5: This gel image displays the purified 
PCR products of (CAG)10-150 after a Double 
Enzymatic Digest. The enzymes, BamHI and Sal 
HF have cut off the long primers leaving only the 
CAG repeat base pairs, represented by the faint 
bands ranging from 25 to 50bp. Faint bands are 
seen in repeats 10-100 and 150 shows nothing. 
This images displays how amplification by PCR 
with long primers induces a heterogeneity seen in 
the CAG sequences alone. This is a 3% agarose 
gel, scanned at 700pmt.  
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PCR with 1.0kb Primers:  
The second part of the 
heterogeneity investigation 
is the amplification of 
CAG repeats with smaller 
primers. As seen in Figure 
6, we performed a 0.5mL 
PCR with smaller G series 
primers. In addition, we 
replicated a new length of 
CAG 120. More 
specifically, Figure 6 
presents the crude 
amplified product- not the 
purified. The image 
displays a step wise increase of band weight along with increasing CAG length, which is 
similar to the long PCR images. Repeats 10 through 100 all display strong bands at 
appropriate weights. Moreover, Figure 6 shows a strong band for CAG 100, and then a smear 
with an unusual light weight band for 150. However, CAG 120 depicts fainter band that is 
slightly heavier than 100. CAG 120 serves as the link between 100 and 150: it displays the 
degradation of a strong band to a smear, which is all due to the increase of repeat length. 
Figure 7 displays the purified G-primer PCR product. The same features found in the last gel 
image, are also found in Figure 7. The bands weight increases along with longer CAG 
lengths, and the CAG 120 serves as the missing link once more. CAG 100 is a strong band, 
and 120 is much fainter and slightly heavier. Then 150 displays a smear with an oddly light 
 
Figure 6: This image displays the crude PCR amplification of 
(CAG)10-150  with shortened G series primers. High intensity 
bands are present for lengths 10 through 60. Meanwhile, the 
intensity of faint bands decreases from 100 to 120; and a smear –
with a low weight band-is present for 150. From 100 to 120 the 
bands become fainter until a smear is shown on 150. This gel 
displays the eventual degradation of the bands because of the 
heterogeneity of lengthy CAG repeats. This is a 0.8% agarose 
gel, scanned at 500pmt.     
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band. Figure 7 –like Figure 6- 
also presents the effects of 
heterogeneity with increasing 
repeat length during PCR. Table 
6 reviews the recordings of the G 
Primer product concentrations. 
The same procedure and 
materials were performed with 
the G primers as with the Long 
PCR products. We used the Nano 
Drop 1000 apparatus and 
deionized water to blank our 
measurements. As seen on Table 
6, the concertation values are 
range between 350ng/µL and 
588ng/µL. In this case, the 
longest repeat, 150 had the 
highest concentration of 
587.2ng/µL. This is a 
considerable finding 
because ideally 150 should 
always have a highest concentration, since it is original started with the longest repeat length. 
The absorbance ratio of all the repeats ranges between 1.8 and 1.9; thusly, showing that the 
products are quite pure. 
 
 
Figure 7: This image displays the purified PCR 
amplification of (CAG)10-150  with shortened G series 
primers. These products are the purified samples from 
Figure 6; however, high intensity bands are present for 
lengths 10 through 100. Furthermore, the intensity of 
faint bands decreases from 100 to 120; and a smear –with 
a low weight band-is present for 150. Similar as to Figure 
6, this gel displays the eventual degradation of the bands 
because of the heterogeneity of lengthy CAG repeats. 
This is a 0.5% agarose gel, scanned at 500pmt. 
Table 6: (CAG)10-150 G Primer Concentrations   
 
(CAG)n ng/uL A260 A280 260/280 
10 458.3 9.166 4.831 1.9 
20 355.5 7.109 3.778 1.88 
30 470.2 9.404 5.133 1.83 
40 379.7 7.593 4.009 1.89 
60 486.8 9.736 5.114 1.9 
100 577.2 11.543 6.21 1.86 
120 478 9.561 5.055 1.89 
150 587.2 11.745 6.191 1.9 
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PCR with 40bp Primers: 
The next step in our investigation 
is the replication (CAG)n repeats 
with even shorter primers. We 
performed 0.5mL PCR 
experiments with M series primers. 
This PCR was kept at the same 
conditions as the previous 
experiments with G series, and 
Long primers.  Figure 8 represents 
the image of the purified M series 
PCR product. The bands in Figure 
8 are less intense than the bands in 
all other previous gel images; and 
this is because of the short length of 
the M series primers. As seen in the 
figure, CAG 10 through 60 show 
distinct bands at about 0.5 kb. CAG 
100 appears as a faint band but is still 
distinguishable at 0.5 kb; also, CAG 
120 is extremely faint and slightly 
heavier than CAG 100. Moreover, CAG 150 shows a smear as expected. In addition to the 
gel image, we recorded the concentrations of each sample with the Nano Drop 1000 
apparatus. As seen on Table 7, the repeats ranged between 300ng/µL and 400ng/µL. The 
 
Figure 8: This gel displays the purified PCR product of 
(CAG)10-150  with shortened M series primers. These M 
primers are shorter than the previous G series primers. 
Weak bands are shown in repeats 20 to 120, and 150 
produced a smear. The shorter repeats amplified much 
better than the longer ones: a pattern shown with 
previous primers. These samples were run on a .5% 
agarose gel and scanned at 450pmt.  
Table 7: (CAG)10-150 M Primer Concentrations   
(CAG)n ng/uL A260 A280 260/280 
10 306.58 6.132 3.296 1.86 
20 315.86 6.317 3.384 1.87 
30 346.48 6.930 3.668 1.89 
40 243.13 4.863 2.565 1.90 
60 382.42 7.648 4.049 1.89 
100 314.73 6.295 3.356 1.88 
120 406.10 8.122 4.274 1.90 
150 373.84 7.477 3.987 1.88 
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absorbance ratio of 260/280 indicates the purity of the samples. All the repeats ratio’s range 
from 1.86 to 1.90. These values indicate that our samples are quite pure.    
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Binding Assay: 
 
-UV Illumination: 
The genesis of the binding assay consisted of 
figuring the correct amount of DNA to bind 
with SYBR Green. Along with this, 
deciphering whether our fluorescent dye was 
emitting light at the correct wavelength. We 
then illuminated samples of the fluorescent 
probe with UV light- one with CAG 10, and 
another without. As seen in Figure 9, the 
SYBR Green is not excited by the short 
wavelength of UV light. No emission is seen. 
Once bound to CAG 10, SYBR Green then 
fluoresces-a bright green color- under UV light. 
This is shows that under UV, the fluorescent 
probe only emits light once bound to DNA.  
 
 
 
 
 
Figure 9: A quartz cuvette holding 
10mM Tris Buffer at a 7.4 pH, and 
SYBR Green. As seen, when illuminated 
with UV light, no fluorescence emissions 
are present.   
 
Figure 10: A quartz cuvette holding 
10mM Tris Buffer at a 7.4 pH, and 
SYBR Green and CAG 10. As seen, 
when illuminated with UV light, 
fluorescence emissions are present. 
The binding of CAG10 with SYBR 
initiates this fluorescence.    
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-SYBR Green Titration  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next we titrated increasing concentrations of CAG 60 into constant amount of SYBR Green. 
This allowed us to view the concentration of at which this fluorescent probe has all of its 
binding sites bound with DNA. Figure 11 displays the fluorescence intensities at the peak 
wavelength of 535nm. The plateau at 300ng/µL depicts the concentration at which all the 
binding sites are filled due to the constant intensity.  
 
 
 
 
 
 
 
Figure 11: This graph depicts the concertation at which CAG 60 fills all of the 
binding sites of SYBR Green. The Relative Fluorescence Units (RFU) are the peak 
intensities of each concentration taken at 535nm.  A plateau forms at a concentration 
of 300ng/µL. The peak intensities were recorded on the Nano Drop Fluorimeter 3300.   
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-Doxorubicin Titration  
 
 
 
 
 
 
 
 
 
 
 
 
A titration curve was also made for the interaction between Doxorubicin and CAG 60. A 
serial dilution of CAG 60 was made and titrated into constant concentrations of Doxorubicin. 
From these samples, the peak intensity- at 595nm- was recorded with the Nano Drop 
Fluorimeter 3300. The intercalation of Doxorubicin is present in Figure 12. With 
concentration plotted against fluoresce intensity, a higher concentration of CAG 60 correlates 
to a lower intensity. This is due to intercalation of Doxorubicin into the double stranded helix 
of CAG 60. Similar to Figure 11, a 300ng/uL concentration of DNA binds all the open sites 
of Doxorubicin. 
 
Figure 12: This graph depicts the concertation at which CAG 60 fills all of the 
binding sites of Doxorubicin. The Relative Fluorescence Units are the peak 
intensities of each concentration taken at 595 nm.  A plateau forms at a concentration 
of 300ng/µL. The peak intensities were recorded on the Nano Drop Fluorimeter 
3300.    
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-Doxorubicin Fluorescence Spectra 
 
 
 
 
 
 
 
 
 
 
As seen in Figure 13, the intensity spectra of Doxorubicin is quite different from the one of 
SYBR Green.  Next, different repeats will be used to show how the increase of length will 
allow for more binding of Doxorubicin, and display fluorescence quenching.
 
Figure 13: This graph shows the fluorescence spectra of 
Doxorubicin after excited at 450nm. The peak intensity is shown to 
be 8.73x106, at wavelength 590nm. The Doxorubicin sample was 
recorded in a 10mM Tris Buffer at pH 7.4- the same conditions as 
the SYBR binding experiments were used with Doxorubicin.  
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Discussion: 
 
CAG/CTG trinucleotide repeats are at the origin and proliferation of multiple 
neurodegenerative diseases through mechanisms that are not fully understood (Li & Bonini, 
2010)-(Kashi & King, 2006). Insight into how these repeats affect DNA polymerase in vivo 
have shown that hairpin structures arise (Wheeler et al., 2012)- (Michlewski & Krzyzosiak, 
2004); however, extended CAG/CTG repeats into the hundreds continue to be troublesome 
even in simple PCR amplifications, and in novel pulling experiments (Stephenson et al., 
2014). Past literature denotes that expanded CAG/CTG repeats in genomic DNA have 
structural polymorphisms in thermodynamically stable forms that are predictable, and non-
canonical states (Lin & Wilson, 2011)- (Amrane et al., 2005). The heterogeneity of these 
repeats  the innate replication difficulties present in in vitro studies and physiological 
conditions in Huntingtins and Myotonic Dystrophy (Lin & Wilson, 2011)- (Cooper, 2009). 
When CAG repeats are being replicated, the strand forms structures that facilitated Taq’s 
ability to jump over sequences and leave shortened replicons (Liu, Chen, Bissler, Sinden, & 
Leffak, 2010) . The agarose gels that represent the amplified CAG sequences merely prove 
how difficult extended repeats are to amplify correctly. Figures 5’s presentation of the 
enzymatic digestion of the repeats displays the trend of heterogeneity of CAG tracts. The 
correlation between increased length, and heterogeneity manifestation. From 10 to 150, the 
bands become less and less defined, and eventually become a smear. Figures 6 through 8 
show the degradation of intense bands to smears, as CAG repeats lengthen. This trend is 
shown in the amplification of repeats 100, 120, and 150. This is seen when using both G and 
M series primers. We were also able to identify that SYBR Green fluoresced only when 
bound to DNA with the images of Figures 9 and 10. In addition, the binding of SYBR Green 
and the CAG lengths will be tested with varying lengths at the correct concentration at which 
all of the SYBR binding sites will be 
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bound to DNA. This will help us probe whether longer lengths will induce higher emission 
intensities. Furthermore, future experiments that will enable us to continue our study of these 
repeats can be performed with the development of a fluorescence assay (Petruska, 
Hartenstine, & Goodman, 1998)- (Ning et al., 2015). Doxorubicin- also called 
Daunomycinone- a well-known anticancer drug, will be used in future fluorescence assays to 
further probe the heterogeneity of CAG150. Doxorubicin intercalates between double stranded 
DNA that is rich in 5’-GC-3’ or 5’-GC-3’ sequences (Ning et al., 2015)-(Box, 2007). 
Furthermore, Doxorubicin acts a fluorophore that emits light at 560nm, once excited at 
480nm (Karukstis et al., 1998)-(Das et al., 2011). When Doxorubicin is in solution alone, its 
full fluorescence is observed; when CAG sequences are added to the solution, Doxorubicin 
will intercalate between the double strands (Hovorka et al., 2010)-(Changenet-Barret et al., 
2013). This intercalation will cause fluorescence quenching. A sudden decrease in fluoresce 
signifies the binding of Doxorubicin (Changenet-Barret et al., 2013),(Galka-Marciniak, 
Urbanek, & Krzyzosiak, 2012),(Yildirim, Park, Disney, & Schatz, 2013). By using the 
Fluromax-3 Fluorimeter, we can record the fluorescence quenching of Doxorubicin by 
titrating in select CAG sequences (Ning et al., 2015)-(Gatchel & Zoghbi, 2005). As seen in 
Figure 12, it seems like 300ng/µL is a concentration at which DNA can fill all of 
Doxorubicin and SYBR Green binding sites. Later on, we will aim to observe an increase of 
fluorescence quenching by titrating longer CAG tracts- starting from CAG10, then ending at 
CAG150 (Ning et al., 2015)-(Chan et al., 2012). Along with the fluorescence assay, we can 
then move towards asymmetrical PCR. In this reaction, fluorescent probes on the primers can 
be used to track the amplification of only one strand of DNA. By replication one strand of 
(CAG)n we can test how well Doxorubicin binds to single strands of sequences that are rich 
with 5’-GC-3’ and 5’-GC-3’. Possibly, a strong fluorescence quenching will be observed 
when performing titration tests with CAG150. The dynamic structure of CAG150 would allow 
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for certain rearrangements that mimic the same GC accessibility as in double stranded 
sequences. As the single stranded repeats increase in length, the fluorescence would continue 
to drop. This pattern between double and single strand (CAG)n may be quite similar.  
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